Intriguingly, in breast cancer, anti-metastatic potential has been attributed to LIFR [102,151], as LIFR downregulation was responsible for the pro-metastatic effect of the E-cadherin suppressor miR-9 [102]. The gene discussed is CDH1; the disease is breast carcinoma.